Principal Investigator
Enrollment Status
Clinical Trial ID
Clinical Trial Summary
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual
clinical practice. TARGET-HCC will create a research registry of participants with HCC within
academic and community real-world practices in order to assess the safety and effectiveness
of the entire spectrum of current and future therapies across diverse populations.
Phase
N/A
Funding Agency/Sponsor
Industrial
Disease
Pancreatic, Liver, and Related Cancers
Enrollment Eligibility
Inclusion Criteria:
1. Male or female patients, age ≥18 years
2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC
cholangiocarcinoma may be included; patients who are candidates for surgical and
non-surgical treatment, as well as those being followed without specific HCC therapy
may be included)
Exclusion Criteria:
1. Inability to provide written informed consent